Voy weight loss review (2026): service and prices

If you're weighing up a Voy weight loss review before you sign up, the short version is this: Voy is a well-marketed, app-led GLP-1 programme with coaching built in — but on our August 2026 price board it sits firmly at the premium end for both Mounjaro and Wegovy. Whether that premium is worth it depends on how much you value the wrap-around support, and how the numbers look once the first-month promo wears off.

This is a price-and-service review, not medical advice. Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medicines, and a prescriber decides whether either is suitable for you. What we can do is lay out the verifiable facts — cost, policies, how Voy is structured — and let you judge.

Who is Voy and how does the service work?

Voy is a UK digital weight-loss service that pairs GLP-1 medication with an app, health coaching and habit-tracking. The pitch is a programme rather than a pharmacy transaction: you complete an online assessment, a prescriber reviews your suitability, and — if appropriate — medication is dispensed through GPhC-registered pharmacy channels with CQC-regulated clinical oversight.

In practice, that means Voy positions itself alongside the likes of Numan and Second Nature: subscription-style services that bundle in behavioural support. If you want more than a box arriving each month, that model has genuine appeal. If you simply want the pen at the keenest price, it's an expensive way to buy it.

Voy weight loss prices: the real figures

Here's where a Voy weight loss review has to be blunt. Voy's headline first-month offers are eye-catching, but the ongoing prices are high. The table below shows Voy's Mounjaro pricing against our cheapest tracked provider, our recommended provider, and two other app-led services, using figures last checked on 25 August 2026.

The pattern is clear. Voy's aggressive £139 first month for the 2.5 mg starter dose looks tempting — but that starter dose lasts only four weeks. You spend far longer on maintenance doses, and there Voy is among the priciest on our board. At 10 mg, Voy's £324 is £64 more than The Weight Clinic and nearly £95 more than the cheapest tracked pharmacy for the identical pen.

Across our whole Mounjaro board, prices run from £131 to £220 for the 2.5 mg dose — an £89 spread for exactly the same medicine. Voy's Wegovy pricing tells a similar story: £144/4 weeks ongoing (with a £69 first month), against a market that starts under £80. You can see the full ranked list on our homepage price table.

What the first-month discount really means

Voy's £139 first-month Mounjaro price and £69 first-month Wegovy price are real, and honestly presented as introductory. But a low starter promo can still leave you paying more over a year if the maintenance price is high — which, in Voy's case, it is.

This is the single most common mistake we see. The 2.5 mg dose is a starter, not a treatment dose; you titrate upward over months. Judge any provider on the dose you'll actually settle on — usually 5, 10 or 15 mg. We walk through this maths in detail in our guide to budget versus premium GLP-1 providers.

Is the coaching worth the premium?

This is the fair question a Voy weight loss review should ask. The medicine does the heavy lifting: in the SURMOUNT-1 trial, tirzepatide produced mean weight loss of around 21% at 10 mg and 22.5% at 15 mg over 72 weeks. Semaglutide (Wegovy) delivered around 15% in its STEP 1 trial. Coaching doesn't change what's in the pen — but structured support can help with adherence, side-effect management and building habits that stick when you eventually come off medication.

Whether that's worth £60–£95 a month more than a leaner service is a personal call. Some people thrive with an app nudging them; others find it noise they're paying for. If you want the clinical essentials — monthly reviews, a clear refund policy, transparent pricing — without the top-tier subscription mark-up, our recommended provider covers those bases for less. The Weight Clinic offers monthly video reviews, £35 off your first order with code NEWME, and a refund if the prescriber declines you — the same honest hooks we'd want from any premium service, at a lower ongoing price.

How Voy compares to other app-led services

Voy, Numan and Second Nature occupy roughly the same premium tier. Numan matches Voy almost pen-for-pen at the top doses (£359 at 15 mg). Second Nature undercuts both slightly on maintenance but layers on a longer behaviour-change programme. If it's the app-led model you're drawn to, it's worth reading our Numan weight loss review alongside this one to see how the coaching propositions differ.

For a wider view of the field, our roundups of the best Mounjaro providers and best Wegovy providers rank the full board on price, monthly reviews and refund policies.

Safety and eligibility

Mounjaro is MHRA-licensed for weight management and recommended by NICE (TA1026). Private eligibility is typically a BMI of 30+, or 27+ with a weight-related condition. Common side effects include nausea, diarrhoea, constipation and tiredness; rarer but serious risks include pancreatitis and gallstones. Doses start low — 2.5 mg weekly for four weeks — and increase gradually to reduce side effects.

If you experience a side effect on any GLP-1 medicine, you can report it through the MHRA Yellow Card scheme. A regulated prescriber — whether at Voy or elsewhere — should always review your suitability before dispensing, and you should never buy these medicines from unregulated sellers or so-called "compounded" alternatives.

Our verdict on Voy

Voy is a credible, regulated, coaching-led service — but this is a price review, and on price it's expensive. The first-month offers are genuine, yet the maintenance costs are among the highest we track for identical medicine. If the app and coaching genuinely change how you'll stick with the programme, that premium may earn its keep. If not, you're paying a wrap-around fee for a pen you can get for £60–£95 less elsewhere each month. To understand exactly how we weigh these factors, see our review methodology.

Frequently asked questions